Literature DB >> 23192868

Neurotropic arboviruses induce interferon regulatory factor 3-mediated neuronal responses that are cytoprotective, interferon independent, and inhibited by Western equine encephalitis virus capsid.

Daniel C Peltier1, Helen M Lazear, Jocelyn R Farmer, Michael S Diamond, David J Miller.   

Abstract

Cell-intrinsic innate immune responses mediated by the transcription factor interferon regulatory factor 3 (IRF-3) are often vital for early pathogen control, and effective responses in neurons may be crucial to prevent the irreversible loss of these critical central nervous system cells after infection with neurotropic pathogens. To investigate this hypothesis, we used targeted molecular and genetic approaches with cultured neurons to study cell-intrinsic host defense pathways primarily using the neurotropic alphavirus western equine encephalitis virus (WEEV). We found that WEEV activated IRF-3-mediated neuronal innate immune pathways in a replication-dependent manner, and abrogation of IRF-3 function enhanced virus-mediated injury by WEEV and the unrelated flavivirus St. Louis encephalitis virus. Furthermore, IRF-3-dependent neuronal protection from virus-mediated cytopathology occurred independently of autocrine or paracrine type I interferon activity. Despite being partially controlled by IRF-3-dependent signals, WEEV also disrupted antiviral responses by inhibiting pattern recognition receptor pathways. This antagonist activity was mapped to the WEEV capsid gene, which disrupted signal transduction downstream of IRF-3 activation and was independent of capsid-mediated inhibition of host macromolecular synthesis. Overall, these results indicate that innate immune pathways have important cytoprotective activity in neurons and contribute to limiting injury associated with infection by neurotropic arboviruses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23192868      PMCID: PMC3554193          DOI: 10.1128/JVI.02858-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Pathogen recognition in the innate immune response.

Authors:  Himanshu Kumar; Taro Kawai; Shizuo Akira
Journal:  Biochem J       Date:  2009-04-28       Impact factor: 3.857

Review 2.  RNA recognition and signal transduction by RIG-I-like receptors.

Authors:  Mitsutoshi Yoneyama; Takashi Fujita
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

3.  Identification of thieno[3,2-b]pyrrole derivatives as novel small molecule inhibitors of neurotropic alphaviruses.

Authors:  Weiping Peng; Daniel C Peltier; Martha J Larsen; Paul D Kirchhoff; Scott D Larsen; Richard R Neubig; David J Miller
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

4.  Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis.

Authors:  Alexandra Schäfer; Alan C Whitmore; Jennifer L Konopka; Robert E Johnston
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

5.  Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3.

Authors:  Brenda Marsh; Susan L Stevens; Amy E B Packard; Banu Gopalan; Brian Hunter; Philberta Y Leung; Christina A Harrington; Mary P Stenzel-Poore
Journal:  J Neurosci       Date:  2009-08-05       Impact factor: 6.167

6.  Toll-like receptor 3 has a protective role against West Nile virus infection.

Authors:  Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

7.  Mitochondrion-enriched anionic phospholipids facilitate flock house virus RNA polymerase membrane association.

Authors:  Kenneth A Stapleford; Doron Rapaport; David J Miller
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

8.  Cell-extracellular matrix interactions regulate neural differentiation of human embryonic stem cells.

Authors:  Wu Ma; Tara Tavakoli; Eric Derby; Yevgeniya Serebryakova; Mahendra S Rao; Mark P Mattson
Journal:  BMC Dev Biol       Date:  2008-09-22       Impact factor: 1.978

9.  Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies.

Authors:  Pauline Ménager; Pascal Roux; Françoise Mégret; Jean-Pierre Bourgeois; Anne-Marie Le Sourd; Anne Danckaert; Mireille Lafage; Christophe Préhaud; Monique Lafon
Journal:  PLoS Pathog       Date:  2009-02-27       Impact factor: 6.823

Review 10.  Viral evasion and subversion of pattern-recognition receptor signalling.

Authors:  Andrew G Bowie; Leonie Unterholzner
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

View more
  15 in total

1.  Manipulation of host factors optimizes the pathogenesis of western equine encephalitis virus infections in mice for antiviral drug development.

Authors:  Pennelope K Blakely; Phillip C Delekta; David J Miller; David N Irani
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

Review 2.  The unique regulation and functions of type III interferons in antiviral immunity.

Authors:  Charlotte Odendall; Jonathan C Kagan
Journal:  Curr Opin Virol       Date:  2015-03-12       Impact factor: 7.090

3.  Differentiation of neurons restricts Arbovirus replication and increases expression of the alpha isoform of IRF-7.

Authors:  Kimberly L W Schultz; Patty S Vernon; Diane E Griffin
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

4.  Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo.

Authors:  Phillip C Delekta; Craig J Dobry; Janice A Sindac; Scott J Barraza; Pennelope K Blakely; Jianming Xiang; Paul D Kirchhoff; Richard F Keep; David N Irani; Scott D Larsen; David J Miller
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

5.  Diverse intracellular pathogens activate type III interferon expression from peroxisomes.

Authors:  Charlotte Odendall; Evelyn Dixit; Fabrizia Stavru; Helene Bierne; Kate M Franz; Ann Fiegen Durbin; Steeve Boulant; Lee Gehrke; Pascale Cossart; Jonathan C Kagan
Journal:  Nat Immunol       Date:  2014-06-22       Impact factor: 25.606

6.  Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells.

Authors:  Lindsay Lundberg; Chelsea Pinkham; Cynthia de la Fuente; Ashwini Brahms; Nazly Shafagati; Kylie M Wagstaff; David A Jans; Sharon Tamir; Kylene Kehn-Hall
Journal:  PLoS Negl Trop Dis       Date:  2016-11-30

7.  Visualization of a neurotropic flavivirus infection in mouse reveals unique viscerotropism controlled by host type I interferon signaling.

Authors:  Xiao-Feng Li; Xiao-Dan Li; Cheng-Lin Deng; Hao-Long Dong; Qiu-Yan Zhang; Qing Ye; Han-Qing Ye; Xing-Yao Huang; Yong-Qiang Deng; Bo Zhang; Cheng-Feng Qin
Journal:  Theranostics       Date:  2017-02-12       Impact factor: 11.556

Review 8.  The Putative Roles and Functions of Indel, Repetition and Duplication Events in Alphavirus Non-Structural Protein 3 Hypervariable Domain (nsP3 HVD) in Evolution, Viability and Re-Emergence.

Authors:  Nurshariza Abdullah; Nafees Ahemad; Konstantinos Aliazis; Jasmine Elanie Khairat; Thong Chuan Lee; Siti Aisyah Abdul Ahmad; Nur Amelia Azreen Adnan; Nur Omar Macha; Sharifah Syed Hassan
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

9.  Discovery of potent broad spectrum antivirals derived from marine actinobacteria.

Authors:  Avi Raveh; Phillip C Delekta; Craig J Dobry; Weiping Peng; Pamela J Schultz; Pennelope K Blakely; Andrew W Tai; Teatulohi Matainaho; David N Irani; David H Sherman; David J Miller
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

10.  Type-1 angiotensin receptor signaling in central nervous system myeloid cells is pathogenic during fatal alphavirus encephalitis in mice.

Authors:  Pennelope K Blakely; Amanda K Huber; David N Irani
Journal:  J Neuroinflammation       Date:  2016-08-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.